2EyesVision
Seeing is believing
Simulations of multifocal corrections before cataract and presbyopia surgery
2EyesVision is a company that specializes in developing and commercializing novel ophthalmic technologies. As a spin-off of the Spanish National Research Council (CSIC), we are driven to revolutionize the ophthalmic industry and solve current unmet patient needs through innovative products.
Our focus lies in addressing highly prevalent ocular conditions such as presbyopia, which affects nearly 100% of the population above 45 years old, and cataracts, whose prevalence is estimated to double with 230 million people affected by 2050. With the combined expertise of Dr. Carlos Dorronsoro (CEO) and Prof. Dr. Susana Marcos (co-inventor and promoter), internationally recognized scientists, we have developed the groundbreaking SimVis Gekko, a binocular visual simulator for an accurate and personalized experience of premium presbyopic and cataract corrections.
Global presence
SimVis Gekko in the Global Market
Our first product, SimVis Gekko, allows patients for the first time to experience the real world through binocular premium presbyopic and cataract corrections before intraocular lens implantation or presbyopic laser refractive surgery
We have already sold the product in 18 different countries!

Milestones to date
- Established company, with highly specialized and seasoned leadership team with balance of business, commercial, engineering, and scientific expertise in the ophthalmology sector
- International Presence in 18 countries across 4 continents with dedicated specialized resellers in 10 territories
- Validated technology by 25+ scientific publications and protected by 8 international patent families
- Regulatory clearance completed in Key Markets
- Specialized manufacturing area: demonstrated scalable factory based on manufacturing cells with ISO9001 certification.
- Strong relationships with top-notch key opinion leaders (KOLs).
- A Medical Advisory Board with 10 of the most influential ophthalmologists and optometrists worldwide.
- Agreements with private international investors.
- Launch of SimVis Gekko 2 in 2025, introducing significant technological enhancements and superior clinical workflow integration.

Awards
- 2017 Madri+d, Best Patent Award
- 2017 Rey Jaime I Award (Marcos, S)
- 2019 Physics, Innovation and Technology Award by the Royal Spanish Physics Society (RSEF) and the BBVA Foundation (Dorronsoro, C)
- 2019 Leonardo Torres Quevedo National Research Award in the area of Engineering
- 2019 South Summit Winner, Health and Biotech
- 2020 Julio Peláez Award to pioneering women in Physics, Chemistry and Mathematics (Marcos, S)
- 2023 Monst Relevant Doctoral Thesis (Barcala, X)
- 2023 Edwin H. Land Medal by Optica (Marcos, S)
- 2023 Transfiere Winner, European Forum for Science, Technology and Innovation
- 2023 LVPEI Startup Challenge for Global Eyecare Innovation Finalist
- 2024: Winner of Health to Market awards by EIT Health Spain
Sim+Vis technology is backed by science
The Sim+Vis Technology™ was developed at the Visual Optics and Biophotonics Lab of the Spanish National Research Council (CSIC), a worldwide recognized research institution, and 2EyesVision has licensed the patents with global exclusivity. More than 25 scientific articles have been published after 10+ years of joint research and development:
Contact US